Hartland,

As far as I know, nothing new has been disclosed about the two ongoing ZEN-3694 trials since I summarized in this post from mid-July, which included info from their last update (slides only) at BIO International. No webcasts in 2017. The single agent ZEN-3694 trial apparently is ongoing but no longer recruiting according to ClinicalTrials.gov (see this post). Seems that Zenith hired Dr. Edward van der Horst as Vice President, Discovery Biology & Pre-Clinical Development in late July (as originally posted by frohlir944) Only event listed on their website event page is BIO Investor Forum 2017, San Francisco, CA, October 17-18, 2017. 

BearDownAZ